Stocks
Orchestra BioMed Holdings, Inc.OBIO
NASDAQHealthcareMedical Devices$5.75
Price as of · delayed, not real-time
A medical device company developing a pacemaker lead that delivers targeted electrical therapy to treat hypertension, with its lead product, Virtue Sirolimus AngioInfusion Balloon, targeting cardiovascular disease. The company is in clinical trials and has not yet generated product revenue, making its stock sensitive to trial results and regulatory milestones. Investors track OBIO for its potential in the hypertension and cardiovascular device markets.
52W Range: $3.46-$6.50
Congressional Interest in Orchestra BioMed Holdings, Inc. (OBIO)
No congressional trades have been disclosed for Orchestra BioMed Holdings, Inc. (OBIO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading OBIO?
No congressional trades found for this stock.